← Leaderboards
Elizabeth Repasky
Roswell Park Cancer Institute Corp
$12,725,917
Attributed
$15,398,351
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,398,351 · 16
By mechanism
R01$12,440,841 · 6
R21$1,108,409 · 3
P30$642,170 · 2
K12$545,604 · 1
R03$331,762 · 2
S10$310,000 · 1
Top collaborators
- Xiang-Yang Wang4 shared
- Scott Andrew Gerber3 shared
- Marina Antoch2 shared
- Suzanne S. Dickerson2 shared
- Minhyung Kim2 shared
- Edith M. Lord2 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- John R. Subjeck$12,071,773
- Xiang-Yang Wang$11,998,946
- Joseph Andrew Spernyak$586,090
- Minhyung Kim$236,225
- Hemn Mohammadpour$1,062,412
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorResponseSignal TransductionNeoplastic CellMalignant NeoplasmsPre-ClinicalClinical TrialsStressCancer TherapyPathway InteractionsNeoplasm MetastasisResistanceTumor ImmunityPublishingResearch PersonnelGrowthMolecularImmuneTumor MicroenvironmentDoseBaseLinkBiologicalClinically Relevant
Grant awards (56)
Preparing Nurse Scientists to Lead the Future of Oncology Research$490,308
K12 · FY2025 · CA · contact PI
Cancer Stress Biology$372,411
P30 · FY2025 · CA · contact PI
Preparing Nurse Scientists to Lead the Future of Oncology Research$55,296
K12 · FY2024 · CA · contact PI
Cancer Stress Biology$44,983
P30 · FY2024 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$549,341
R01 · FY2023 · CA · contact PI
Acquisition of a calScreener Isothermal Microcalorimetry System for Translational Cancer Metabolism Research at Roswell Park$310,000
S10 · FY2023 · OD · contact PI
Cell Stress and Biophysical Therapies$42,341
P30 · FY2023 · CA · contact PI
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors$555,814
R01 · FY2022 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$549,341
R01 · FY2022 · CA · contact PI
Cell Stress and Biophysical Therapies$44,540
P30 · FY2022 · CA · contact PI
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors$567,157
R01 · FY2021 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$560,552
R01 · FY2021 · CA · contact PI
Cell Stress and Biophysical Therapies$45,965
P30 · FY2021 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$560,552
R01 · FY2020 · CA · contact PI
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors$558,602
R01 · FY2020 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$326,813
R01 · FY2020 · CA · contact PI
Cell Stress and Biophysical Therapies$45,965
P30 · FY2020 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$574,981
R01 · FY2019 · CA · contact PI
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors$541,844
R01 · FY2019 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$317,333
R01 · FY2019 · CA · contact PI
Activating adrenergic receptors to suppress the anti-graft immune response and improve survival of composite tissue allografts$214,750
R21 · FY2019 · AI · contact PI
(PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?$181,227
R21 · FY2019 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$155,000
R01 · FY2019 · CA · contact PI
Cell Stress and Biophysical Therapies$45,965
P30 · FY2019 · CA · contact PI
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors$576,552
R01 · FY2018 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$327,475
R01 · FY2018 · CA · contact PI
Activating adrenergic receptors to suppress the anti-graft immune response and improve survival of composite tissue allografts$257,700
R21 · FY2018 · AI · contact PI
(PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?$224,199
R21 · FY2018 · CA · contact PI
Comparing the Impact of Cold Stress on Anti-tumor Immunity in Young and Aged Mice$85,750
R03 · FY2016 · AG · contact PI
Comparing the Impact of Cold Stress on Anti-tumor Immunity in Young and Aged Mice$85,750
R03 · FY2015 · AG · contact PI
Exploiting thermoregulatory mechanisms to improve radiation therapy of cancer$340,381
R01 · FY2013 · CA · contact PI
Exploiting thermoregulatory mechanisms to improve radiation therapy of cancer$357,424
R01 · FY2012 · CA · contact PI
Exploiting thermoregulatory mechanisms to improve radiation therapy of cancer$352,877
R01 · FY2011 · CA · contact PI
Exploiting thermoregulatory mechanisms to improve radiation therapy of cancer$359,237
R01 · FY2010 · CA · contact PI
Analysis of Patient Tumor Responses to Apo2L/TRAIL$309,799
R01 · FY2010 · CA · contact PI
Exploiting thermoregulatory mechanisms to improve radiation therapy of cancer$354,818
R01 · FY2009 · CA · contact PI
Analysis of Patient Tumor Responses to Apo2L/TRAIL$305,795
R01 · FY2009 · CA · contact PI
Whole Body Hyperthermia and Anti-Tumor Immune Response$287,503
R01 · FY2009 · CA · contact PI
Regional Cancer Center Consortium Annual Meetings$4,855
R13 · FY2009 · CA · contact PI
Analysis of Patient Tumor Responses to Apo2L/TRAIL$301,909
R01 · FY2008 · CA · contact PI
Whole Body Hyperthermia and Anti-Tumor Immune Response$283,824
R01 · FY2008 · CA · contact PI
Predicting Response of Pancreatic Tumors to Therapy$80,576
R03 · FY2008 · CA · contact PI
Regional Cancer Center Consortium Annual Meetings$4,855
R13 · FY2008 · CA · contact PI
Analysis of Patient Tumor Responses to Apo2L/TRAIL$298,135
R01 · FY2007 · CA · contact PI
Whole Body Hyperthermia and Anti-Tumor Immune Response$280,252
R01 · FY2007 · CA · contact PI
Predicting Response of Pancreatic Tumors to Therapy$79,686
R03 · FY2007 · CA · contact PI
Regional Cancer Center Consortium Annual Meetings$4,855
R13 · FY2007 · CA · contact PI
Analysis of Patient Tumor Responses to Apo2L/TRAIL$303,266
R01 · FY2006 · CA · contact PI
Whole Body Hyperthermia and Anti-Tumor Immune Response$285,134
R01 · FY2006 · CA · contact PI
Regional Cancer Center Consortium Annual Meetings$5,000
R13 · FY2006 · CA · contact PI
Whole Body Hyperthermia and Anti-Tumor Immune Response$288,360
R01 · FY2005 · CA
Thermal stimulation of the PMNs: a cancer CAM$230,533
R21 · FY2005 · CA
WHOLE BODY HYPERTHERMIA &THE ANTI TUMOR IMMUNE RESPONSE$271,610
R01 · FY2003 · CA
WHOLE BODY HYPERTHERMIA &THE ANTI TUMOR IMMUNE RESPONSE$265,059
R01 · FY2002 · CA
WHOLE BODY HYPERTHERMIA &THE ANTI TUMOR IMMUNE RESPONSE$265,059
R01 · FY2001 · CA
WHOLE BODY HYPERTHERMIA &THE ANTITUMOR IMMUNE RESPONSE$209,042
R01 · FY2000 · CA